Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-11-30

Clinical Trial Update: A Study of ATI-50002 Topical Solution for the Treatment of Vitiligo [Phase 2]

View source ↗

Summary

Phase 2 trial update of ATI-50002 topical solution for vitiligo completed; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ATI-50002 topical solution (ATI-50002)

Snippet

Sponsor: Aclaris Therapeutics, Inc. | Conditions: Vitiligo | Phase 2 | Status: COMPLETED | Results posted: 2020-11-30